Cannabis stocks could race to higher highs in New Year 2022, including Xebra Brands (CSE:XBRA)(OTCQB:XBRAF), Aurora Cannabis (NASDAQ:ACB)(TSX:ACB), Canopy Growth (TSX:WEED)(NASDAQ:CGC), Tilray Inc. (NASDAQ:TLRY)(TSX:TLRY), and OrganiGram Holdings (NASDAQ:OGI)(TSX:OGI) thanks to substantial catalysts. For one, in the U.S., Congress could decriminalize cannabis this spring. In fact, according to The Hill, federal proposals could establish banking services for the cannabis industry, and purge the criminal records of marijuana offenders. Two, a growing number of Americans want to see cannabis legalization. According to a Gallup Poll, for example, 68% of U.S. adults support it.
Three, according to analysts at Prohibition Partners, global sales of CBD, medical, and recreational cannabis sales topped $37.4 billion in 2021, and could be on course to see $102 billion in sales by 2026. Even analysts at Vantage Market Research say the global market could run to $128.92 billion by 2028.
Xebra Brands Commences Trading on the OTCQB
Xebra Brands Ltd. just announced that it has been upgraded to trade on the OTCQB Venture Markets effective today Monday January 10th, 2022. The ticker remains unchanged: XBRAF.
It is anticipated that Xebra’s upgraded listing to the OTCQB will provide greater liquidity and a more seamless trading experience for U.S. investors. With enhanced reporting requirements and greater transparency required with the OTCQB listing, the upgrade also provides exemptions from U.S. state securities laws or “blue sky” exemptions which may help to further increase liquidity and expand investment advisors’ ability to research and recommend investment in Xebra.
In addition, Xebra has completed an application for DTC eligibility, which has been submitted to the Financial Industry Regulatory Authority (FINRA).
Other related developments from around the markets include:
Aurora Cannabis, the Canadian company defining the future of cannabinoids worldwide, announced the delivery of a cannabis shipment worth approximately C$10 million – the company’s largest ever shipment to Israel, and what is believed to be the largest export of medical Cannabis into the Israeli market. Delivered in December, the shipment will be recognized as revenue in Aurora’s FY22 Q2 period. The sale builds on the Company’s growing presence in Israel, a key market as Aurora continues to strengthen its international medical business. As the leading Canadian licensed producer (LP) in global medical cannabis by revenue, Aurora has strategically focused on international expansion to bolster its diversified business portfolio. The Company also recently entered into a joint venture in The Netherlands to participate in the Controlled Cannabis Supply Chain Experiment, an adult-use pilot program.
Canopy Growth announced the release of its Environmental, Social, and Governance (ESG) Report for calendar year 2020, as well as qualitative details on some key activities that occurred in 2021. The Report recognizes Canopy’s current progress and describes its priorities and approach to ESG as part of its long-term path towards responsible and sustainable growth. “As the cannabis industry becomes more established, we recognize the role we must play to ensure that progress is achieved responsibly and sustainably,” said David Klein, CEO Canopy Growth. “We are committed to realizing our vision of unleashing the power of cannabis to improve lives and our inaugural ESG report is the next step in our leadership journey, creating accountability for ourselves, and the cannabis industry.”
Tilray Inc. announced that the Company will release financial results for its second quarter fiscal 2022 ended November 30, 2021 before financial markets open on January 10, 2022. Tilray executives will host a conference call and live audio webcast to discuss these results at 8:30 am Eastern Time.
OrganiGram Holdings, a leading licensed producer of cannabis, announced it will report earnings results for its first quarter fiscal 2022 ended November 30, 2021 on Tuesday, January 11, 2022 before market open.
Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Xebra Brands has paid three thousand five hundred dollars for advertising and marketing services to be distributed by Winning Media. Winning Media is only compensated for its services in the form of cash-based compensation. Winning Media owns ZERO shares of Xebra Brands. Click here for disclaimer.